Omar H. Khalil
Partner, Sante Ventures
Omar H. Khalil manages Santé’s Boston Office and concentrates on biotechnology, where he partners with scientific founders and entrepreneurs across multiple therapeutic areas and modalities. Omar joined Santé in 2007 and rejoined in 2020 after holding various transactional and operational leadership roles within the pharmaceutical and biotech industry. He held senior leadership roles with Baxter International, … Read more
James Eadie, MD
Partner, Santé Ventures
James Eadie, MD received his MD from Harvard Medical School, an MBA from the University of Texas McCombs School Of Business, and a BS in bioengineering, Summa Cum Laude, from the University of Michigan. He is board certified in emergency medicine and completed his residency at Massachusetts General Hospital and Brigham and Women’s Hospital. Previously, … Read more
Laurent Humeau, PHD
Chief Scientific Officer, Inovio Pharmaceuticals
Laurent Humeau is Chief Scientific Officer at Inovio. He works to ensure continuous and strategic growth of INOVIO’s pipeline by introducing a constant flow of innovative concepts and cycling them from early-stage discovery and development through clinical application and patient monitoring. He provides technical and strategic leadership across multiple teams that are essential to upstream … Read more
Sangwoo Lee
Managing Director — Korea Investment Partners US Inc.
Mr. Lee is Head of Korea Investment Partners (KIP’s) US office based in Silicon Valley and actively explores cross-border investments to contribute to the global expansion of Korea Investment Partners. He is currently managing over 12 companies in his investment portfolio and participates actively on more than 7 boards. Portfolio companies range from biotech/healthcare companies … Read more
Jose Ochoa
Partner, Flerie Invest
José Ochoa is a Venture Partner at Flerie Invest, a European biotech and pharma investor managing a portfolio of more than 25 companies in the US, UK, Sweden and Israel. With over 25 years of experience in the life sciences sector, José has successfully executed a variety of transactions, including mergers, acquisitions, joint ventures, and … Read more
Niranjan Y. Sardesai, PhD
Founder, President & CEO
Dr. Sardesai founded Geneos after building Inovio Pharmaceuticals into a Phase III cancer and infectious disease immunotherapy company serving as its Chief Operating Officer. He held positions of increasing responsibility after joining the company in 2006 where he helped formulate the company’s product development and growth strategies and reorganized the company into a DNA vaccine … Read more
David Wurtman, MD, MBA
Chief Business Officer
Dr. Wurtman has served as President & CEO of Lyric Pharmaceuticals, an ICU therapeutic development company which he founded, built and successfully funded, and as CMO and an early employee of Lucid Diagnostics, a medical device-diagnostic company which went public via IPO in 2021. He has led or advised on ~30 in-licensing, out-licensing and co-development … Read more
Roberto De Ponti
Managing Director & General Partner, 3B Future Health Ventures sarl
Roberto is Managing Director and General Partner of 3B Future Health Ventures sarl. Prior to this, Roberto was Head of Corporate Business Development at Helsinn. Roberto has held several Senior Director positions in various pharmaceutical companies including Pfizer, Indena, Pharmacia & Upjohn, Nerviano Medical Sciences and Boehringer Mannheim. His extensive background in the pharmaceutical industry … Read more
Jing Bao, MD, PhD
Partner, Shanghai Healthcare Capital (SHC)
Dr. Jing Bao is a Partner at Shanghai HealthCare Capital (SHC). A physician-scientist with a PhD from the Weizmann Institute of Science, Dr. Bao possesses extensive experience in life science investment, patient care, drug development, clinical research and regulation. Dr. Bao also holds the position of Adjunct Professor at the China Infectious Diseases Clinical Center … Read more